Please assess the completion status of the following clinical trial:

Trial Title: Regulation of Coagulation in Orthopedic Surgery to Prevent DVT and PE, a Controlled, Double-blind, Randomized Study of BAY 59-7939 in the Extended Prevention of VTE in Patients Undergoing Elective Total Hip Replacement

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Male and female patients aged 18 years or above~* Patients scheduled for elective total hip replacement~Exclusion Criteria:~* Planned, staged total bilateral hip replacement~* Active bleeding or high risk of bleeding contraindicating treatment with low molecular weight heparin~* Contraindication listed in the labeling or conditions precluding patient treatment with enoxaparin~* Conditions prohibiting bilateral venography (e.g. amputation of one leg, allergy to contrast media)

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Arm 1 (Type: EXPERIMENTAL): None
- Arm 2 (Type: ACTIVE_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).